To view the PDF file, sign up for a MySharenet subscription.

APN - Aspen Pharmacare Holdings - Appointment Of Director

Release Date: 11/12/2009 14:51
Code(s): APN
Wrap Text

APN - Aspen Pharmacare Holdings - Appointment Of Director ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number 1985/0002935/06 Share code: APN ISIN: ZAE000066692 ("Aspen" or "the Company") APPOINTMENT OF DIRECTOR Following GlaxoSmithKline`s acquisition of an equity stake in Aspen, Abbas Hussain has been appointed to Aspen`s Board with effect from 7 December 2009. Abbas is GlaxoSmithKline`s President: Emerging Markets. His extensive international pharmaceutical expertise will add value to the Aspen Group. Woodmead 11 December 2009 Sponsor: Investec Bank Limited Date: 11/12/2009 14:51:01 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Share This Story